BNP PARIBAS ASSET MANAGEMENT Holding S.A. Cuts Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

BNP PARIBAS ASSET MANAGEMENT Holding S.A. lessened its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 14.2% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 432,216 shares of the medical device company’s stock after selling 71,423 shares during the quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. owned 0.22% of Cooper Companies worth $47,691,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Innealta Capital LLC acquired a new position in Cooper Companies during the 2nd quarter worth approximately $25,000. Ashton Thomas Securities LLC acquired a new position in shares of Cooper Companies during the third quarter worth $25,000. Covestor Ltd increased its holdings in Cooper Companies by 305.9% in the first quarter. Covestor Ltd now owns 276 shares of the medical device company’s stock valued at $28,000 after buying an additional 208 shares during the last quarter. Crewe Advisors LLC raised its stake in Cooper Companies by 286.4% in the second quarter. Crewe Advisors LLC now owns 340 shares of the medical device company’s stock valued at $30,000 after buying an additional 252 shares in the last quarter. Finally, Tortoise Investment Management LLC lifted its holdings in Cooper Companies by 75.4% during the 2nd quarter. Tortoise Investment Management LLC now owns 393 shares of the medical device company’s stock worth $34,000 after buying an additional 169 shares during the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on COO shares. Piper Sandler raised their target price on Cooper Companies from $115.00 to $120.00 and gave the stock an “overweight” rating in a research report on Thursday, August 29th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Thursday, August 29th. Stifel Nicolaus reaffirmed a “buy” rating and issued a $115.00 target price (up from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. Robert W. Baird boosted their price target on shares of Cooper Companies from $118.00 to $125.00 and gave the company an “outperform” rating in a research report on Thursday, August 29th. Finally, Wells Fargo & Company raised their price objective on Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a report on Thursday, August 29th. Four equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $117.00.

Cooper Companies Trading Up 0.9 %

Shares of COO stock opened at $99.96 on Friday. The company has a market capitalization of $19.91 billion, a P/E ratio of 55.69, a price-to-earnings-growth ratio of 2.14 and a beta of 0.99. The company has a current ratio of 1.99, a quick ratio of 1.18 and a debt-to-equity ratio of 0.33. The business’s 50 day moving average is $106.11 and its two-hundred day moving average is $98.20. The Cooper Companies, Inc. has a twelve month low of $82.21 and a twelve month high of $112.38.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.05. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The company had revenue of $1 billion for the quarter, compared to analysts’ expectations of $997.30 million. During the same period in the previous year, the company posted $0.84 EPS. Cooper Companies’s revenue was up 7.8% compared to the same quarter last year. Equities analysts forecast that The Cooper Companies, Inc. will post 3.65 EPS for the current year.

Insider Buying and Selling at Cooper Companies

In other Cooper Companies news, CAO Agostino Ricupati sold 1,601 shares of the business’s stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total transaction of $172,956.03. Following the sale, the chief accounting officer now directly owns 4,818 shares in the company, valued at approximately $520,488.54. The trade was a 24.94 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Daniel G. Mcbride sold 114,992 shares of the company’s stock in a transaction on Wednesday, September 4th. The stock was sold at an average price of $105.48, for a total transaction of $12,129,356.16. Following the transaction, the chief operating officer now directly owns 44,696 shares in the company, valued at approximately $4,714,534.08. This trade represents a 72.01 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 256,373 shares of company stock valued at $27,637,427. 2.00% of the stock is owned by corporate insiders.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.